- Home
- RKDA vs OGEN Comparison
RKDA vs OGEN Comparison
Compare RKDA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKDA
- OGEN
- Stock Information
- Founded
- RKDA 2002
- OGEN 1996
- Country
- RKDA United States
- OGEN United States
- Employees
- RKDA N/A
- OGEN N/A
- Industry
- RKDA Agricultural Chemicals
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- RKDA Industrials
- OGEN Health Care
- Exchange
- RKDA Nasdaq
- OGEN Nasdaq
- Market Cap
- RKDA 5.3M
- OGEN 4.6M
- IPO Year
- RKDA 2015
- OGEN N/A
- Fundamental
- Price
- RKDA $4.35
- OGEN $4.13
- Analyst Decision
- RKDA Strong Buy
- OGEN
- Analyst Count
- RKDA 1
- OGEN 0
- Target Price
- RKDA $6.00
- OGEN N/A
- AVG Volume (30 Days)
- RKDA 13.5K
- OGEN 656.3K
- Earning Date
- RKDA 08-12-2025
- OGEN 08-08-2025
- Dividend Yield
- RKDA N/A
- OGEN N/A
- EPS Growth
- RKDA N/A
- OGEN N/A
- EPS
- RKDA N/A
- OGEN N/A
- Revenue
- RKDA $5,258,000.00
- OGEN N/A
- Revenue This Year
- RKDA $29.40
- OGEN N/A
- Revenue Next Year
- RKDA $25.00
- OGEN N/A
- P/E Ratio
- RKDA N/A
- OGEN N/A
- Revenue Growth
- RKDA 24.92
- OGEN N/A
- 52 Week Low
- RKDA $2.40
- OGEN $3.12
- 52 Week High
- RKDA $10.31
- OGEN $75.60
- Technical
- Relative Strength Index (RSI)
- RKDA 46.20
- OGEN 47.04
- Support Level
- RKDA $4.15
- OGEN $3.41
- Resistance Level
- RKDA $4.84
- OGEN $4.85
- Average True Range (ATR)
- RKDA 0.33
- OGEN 0.58
- MACD
- RKDA -0.11
- OGEN 0.01
- Stochastic Oscillator
- RKDA 20.91
- OGEN 42.49
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.